Entries by Phil Case

AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases – Large Population Screening Study Reached Key Milestone with Over 2,000 Confirmed Cases

AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases Large Population Screening Study Reached Key Milestone with Over 2,000 Confirmed Cases Philadelphia, PA, October 4, 2021 – AnPac Bio-Medical Science Co., Ltd. (Nasdaq:ANPC, “AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United […]

AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%

AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3% PHILADELPHIA, October 1, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the six months […]

AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency

AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency PHILADELPHIA, September 30, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, announced today that it has received a written notification (the “Notification […]

AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60%

AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60% Philadelphia, Pennsylvania, September 3, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that its subsidiary, Anpac Bio-Medical Science (Lishui) Co., Ltd. […]

AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists

AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists Philadelphia, Pennsylvania, August 30, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that its Philadelphia, PA Clinical Laboratory Improvement Amendments (“CLIA”) certified laboratory […]

AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) for Registration Testing of Its Multi-Cancer CDA Device

AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) for Registration Testing of Its Multi-Cancer CDA Device PHILADELPHIA, Aug. 23, 2021 – via Investor Wire – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, […]

AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO

AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO Philadelphia, Pennsylvania, August 17, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that it has hired Dr. Sunil Pandit, a successful life sciences veteran […]

AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions

AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions Philadelphia, Pennsylvania, August 5, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that Announced that AnPac Bio and Roche […]

AnPac Bio Announces Appointment of New Independent Director Independent Director has Strong Track Record at US Fortune 500 Companies

AnPac Bio Announces Appointment of New Independent Director Independent Director has Strong Track Record at US Fortune 500 Companies Philadelphia, Pennsylvania, July 23, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that Mr. Chao Feng, […]

AnPac Bio Began Generating Contract Medical Device R&D Revenue Also in Final Stages of Partnership/Cooperation Discussions with Major Corporations

FOR IMMEDIATE RELEASE AnPac Bio Enters into Contract with Cancer Treatment Company JV Partner Philadelphia, Pennsylvania, July 21, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it […]

©2021 Anpac Bio-Medical Science Co., Ltd.